Immunotherapy treatment was effective at reducing attack recurrence in patients with NMOSD but was less effective for MOGAD, a study found.
ALG-801 is designed to inhibit activation of the Smad2/3 pathway, which is critically involved in the pathogenesis of PAH. The United States Food and Drug Administration (FDA) has granted Orphan Drug ...
Support vector machine and logistic regression models integrating multilevel functional features like resting-state functional connectivity, amplitude of low-frequency fluctuation, and regional ...
All cases were diagnosed according to pediatric European Society for Blood and Marrow Transplantation criteria 2 to 4 days before modified Seattle or Baltimore criteria would have allowed diagnosis.
The researchers used the Paris criteria to reach a final diagnosis. A team of international researchers presented the rare case of a male patient with autoimmune hepatitis-primary biliary cholangitis ...
The differential diagnosis of platelet disorders in 22q11.2DS is critical to optimizing patient care and outcomes. The diagnosis and management of thrombocytopenia in 22q11.2 deletion syndrome ...
Researchers found that pediatric male patients with hemophilia are at a greater risk of falls due to poor dynamic balance.
Researchers observed that sC5b-9 levels were proportional to the annual relapse rate after 1 year of follow up. Patients with neuromyelitis optica spectrum disorder (NMOSD) and high sC5b-9 levels ...
Which of the statements below about the epidemiology of fetal and neonatal alloimmune thrombocytopenia (FNAIT) are correct? Select one of the options for each question, then submit your answers to see ...
Bone marrow flow cytometry is one of the most efficient ways to diagnose or exclude PNH. A patient with a history of cortical vein thrombosis with new-onset pancytopenia was diagnosed with paroxysmal ...
Literature reports indicate that among individuals of European ancestry residing in North America, the frequency of HPA-4b is less than 0.1%. Fetal and neonatal alloimmune thrombocytopenia (FNAIT) ...